marketcaparena
Search

    DNTH

    Dianthus Therapeutics, Inc. /DE/

    Company overview

    Market capitalization
    $4.91B
    Employees
    92
    Latest publication
    2026-09-29
    About Dianthus Therapeutics, Inc. /DE/

    Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein; and DNTH212, a bifunctional fusion protein that targets plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell function. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Revenue463,000USD284,000USD396,000USD193,000USD1,163,000USD1,326,000USD2,172,000USD1,863,000USD
    Cost Of Revenue76,000USD—99,000USD99,000USD133,000USD78,000USD116,000USD111,000USD
    Gross Profit387,000USD284,000USD396,000USD193,000USD1,163,000USD1,326,000USD2,172,000USD1,863,000USD
    Research Development34,528,000USD59,895,000USD32,488,999USD26,251,000USD27,003,000USD26,413,000USD25,544,000USD18,070,000USD
    Selling General Administrative12,468,000USD9,930,000USD8,195,000USD8,869,000USD7,337,000USD6,829,000USD6,528,000USD5,997,000USD
    Total Operating Expenses46,920,000USD69,825,000USD40,684,000USD35,120,000USD34,340,000USD33,242,000USD32,072,000USD24,067,000USD
    Operating Income-46,533,000USD-69,541,000USD-40,288,000USD-34,927,000USD-33,177,000USD-31,916,000USD-29,900,000USD-22,204,000USD
    Interest Income6,265,000USD5,267,000USD3,658,000USD3,403,000USD3,791,000USD3,990,000USD4,445,000USD4,708,000USD
    Net Interest Income6,265,000USD5,267,000USD3,658,000USD3,403,000USD3,791,000USD3,990,000USD4,445,000USD4,708,000USD
    Income Before Tax-40,834,000USD97,905,000USD-36,765,000USD-31,629,000USD-29,511,000USD-28,440,000USD-25,174,000USD-17,607,000USD
    Net Income-40,834,000USD97,905,000USD-36,765,000USD-31,629,000USD-29,511,000USD-28,440,000USD-25,174,000USD-17,607,000USD
    Net Income From Continuing Ops-40,834,000USD-64,432,000USD-36,765,000USD-31,629,000USD-29,511,000USD-28,440,000USD-25,174,000USD-17,607,000USD
    Ebit-40,834,000USD97,905,000USD-36,765,000USD-31,629,000USD-29,511,000USD-28,440,000USD-25,174,000USD-17,607,000USD
    Ebitda-40,758,000USD98,164,000USD-36,738,000USD-31,530,000USD-29,378,000USD-28,362,000USD-25,058,000USD-17,496,000USD
    Depreciation And Amortization76,000USD259,000USD27,000USD99,000USD133,000USD78,000USD116,000USD111,000USD
    Reconciled Depreciation76,000USD97,000USD99,000USD99,000USD133,000USD78,000USD116,000USD111,000USD
    Total Other Income Expense Net5,699,000USD167,446,000USD3,523,000USD3,298,000USD3,666,000USD3,476,000USD4,726,000USD4,597,000USD
    Selling And Marketing Expenses———————111,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USD
    Total Revenue2,036,000USD6,235,000USD2,826,000USD——
    Gross Profit2,036,000USD6,235,000USD2,826,000USD-376,000USD-6,000USD
    Research Development145,638,000USD83,105,000USD32,841,000USD27,899,000USD5,782,000USD
    Selling General Administrative34,331,000USD24,994,000USD18,159,000USD7,828,000USD3,486,000USD
    Total Operating Expenses179,969,000USD108,099,000USD51,000,000USD35,351,000USD9,262,000USD
    Operating Income-177,933,000USD-101,864,000USD-48,174,000USD-35,727,000USD-9,268,000USD
    Interest Income16,119,000USD17,365,000USD2,960,000USD——
    Net Interest Income16,119,000USD17,365,000USD2,960,000USD——
    Income Before Tax-162,337,000USD-84,969,000USD-43,555,000USD-35,491,000USD-9,431,000USD
    Net Income-162,337,000USD-84,969,000USD-43,555,000USD-35,491,000USD-9,431,000USD
    Net Income From Continuing Ops-162,337,000USD-84,969,000USD-43,108,000USD——
    Ebit-162,337,000USD-84,969,000USD-43,555,000USD-35,491,000USD-9,268,000USD
    Ebitda-161,909,000USD-84,557,000USD-43,200,000USD-35,115,000USD-9,262,000USD
    Depreciation And Amortization428,000USD412,000USD355,000USD376,000USD6,000USD
    Reconciled Depreciation428,000USD412,000USD301,000USD——
    Total Other Income Expense Net15,596,000USD16,895,000USD4,619,000USD236,000USD-163,000USD
    Cost Of Revenue—412,000USD355,000USD376,000USD6,000USD
    Selling And Marketing Expenses——355,000USD376,000USD6,000USD
    Income Tax Expense——187,105USD236,000USD—
    Interest Expense————163,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets1,213,271,000USD1,246,884,000USD530,922,000USD577,445,000USD326,076,000USD348,580,000USD374,008,000USD354,248,000USD
    Cash And Equivalents110,549,000USD———————
    Cash And Short Term Investments886,813,000USD1,111,259,000USD404,295,000USD402,613,000USD257,389,000USD263,230,000USD275,241,000USD281,123,000USD
    Short Term Investments776,264,000USD483,592,000USD353,208,000USD346,629,000USD244,152,000USD253,114,000USD252,449,000USD247,452,000USD
    Long Term Investments303,633,000USD113,868,000USD110,135,000USD152,874,000USD51,705,000USD68,308,000USD81,728,000USD61,482,000USD
    Total Current Assets897,537,000USD1,119,911,000USD409,438,000USD413,825,000USD263,605,000USD270,999,000USD280,904,000USD287,489,000USD
    Other Current Assets10,618,000USD7,422,000USD5,041,000USD6,212,000USD6,177,000USD6,769,000USD4,856,000USD5,073,000USD
    Total Liabilities41,246,000USD———————
    Total Current Liabilities34,389,000USD38,283,000USD30,732,000USD23,855,000USD20,093,000USD16,953,000USD18,452,000USD15,710,000USD
    Other Current Liabilities26,101,000USD———————
    Total Stockholder Equity1,172,025,000USD1,201,314,000USD493,401,000USD546,454,000USD303,079,000USD328,606,000USD352,477,000USD337,898,000USD
    Total Equity Including Noncontrolling Interest1,172,025,000USD———————
    Deferred Revenue1,524,000USD———————
    Deferred Revenue Non Current5,944,000USD———————
    Net Receivables106,000USD1,230,000USD102,000USD5,000,000USD39,000USD1,000,000USD807,000USD1,293,000USD
    Property Plant Equipment Net1,641,000USD1,567,000USD1,633,000USD1,491,000USD1,585,000USD1,638,000USD1,747,000USD541,000USD
    Accounts Payable6,390,000USD5,274,000USD9,725,000USD6,705,000USD5,404,000USD8,269,000USD4,579,000USD7,572,000USD
    Short Term Debt374,000USD399,000USD367,000USD217,000USD211,000USD226,000USD320,000USD311,000USD
    Common Stock55,000USD54,000USD43,000USD43,000USD32,000USD32,000USD31,000USD29,000USD
    Retained Earnings-427,778,000USD-377,563,000USD-336,729,000USD-272,297,000USD-235,532,000USD-203,903,000USD-174,392,000USD-145,952,000USD
    Accumulated Other Comprehensive Income-2,128,000USD-575,000USD489,000USD163,000USD98,000USD270,000USD106,000USD681,000USD
    Total Liab—45,570,000USD37,521,000USD30,991,000USD22,997,000USD19,974,000USD21,531,000USD16,350,000USD
    Other Current Liab—31,125,000USD19,452,000USD15,979,000USD13,999,000USD7,979,000USD13,074,000USD7,727,000USD
    Capital Stock—54,000USD43,000USD43,000USD32,000USD32,000USD31,000USD29,000USD
    Cash—627,667,000USD51,087,000USD55,984,000USD13,237,000USD10,116,000USD22,792,000USD33,671,000USD
    Current Deferred Revenue—1,485,000USD1,188,000USD954,000USD479,000USD479,000USD479,000USD100,000USD
    Net Debt—-626,303,000USD-49,701,000USD-54,699,000USD-11,907,000USD-8,720,000USD-21,301,000USD-33,360,000USD
    Short Long Term Debt Total—1,364,000USD1,386,000USD1,285,000USD1,330,000USD1,396,000USD1,491,000USD311,000USD
    Property Plant Equipment Gross—1,903,000USD1,937,000USD1,768,000USD1,835,000USD1,858,000USD1,940,000USD708,000USD
    Common Stock Shares Outstanding—48,032,742shares37,794,088shares37,794,088shares35,822,308shares35,791,000shares35,033,773shares34,236,728shares
    Non Current Assets Total—126,973,000USD121,484,000USD163,620,000USD62,471,000USD77,581,000USD93,104,000USD66,759,000USD
    Non Current Liabilities Total—7,287,000USD6,789,000USD7,136,000USD2,904,000USD3,021,000USD3,079,000USD640,000USD
    Non Currrent Assets Other—11,538,000USD9,716,000USD9,255,000USD9,181,000USD7,635,000USD9,629,000USD4,736,000USD
    Net Working Capital—1,081,628,000USD378,706,000USD389,970,000USD243,512,000USD254,046,000USD262,452,000USD271,779,000USD
    Unclassified Non Current Liabilities—7,287,000USD6,789,000USD7,136,000USD2,904,000USD3,021,000USD3,079,000USD—
    Unclassified Equity—1,579,344,000USD829,555,000USD818,502,000USD538,449,000USD532,175,000USD526,701,000USD483,111,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets530,922,000USD374,008,000USD179,405,000USD83,110,000USD189,934,000USD161,619,000USD161,514,000USD157,313,000USD
    Other Current Assets5,041,000USD4,856,000USD3,255,000USD905,000USD3,767,000USD2,692,000USD4,114,000USD2,751,000USD
    Total Liab37,521,000USD21,531,000USD10,535,000USD9,454,000USD17,262,000USD17,713,000USD20,321,000USD11,665,000USD
    Total Stockholder Equity493,401,000USD352,477,000USD168,870,000USD73,656,000USD172,672,000USD143,906,000USD141,193,000USD145,648,000USD
    Other Current Liab19,452,000USD13,074,000USD6,504,000USD6,608,000USD7,823,000USD7,670,000USD11,303,000USD6,927,000USD
    Common Stock43,000USD31,000USD15,000USD61,000USD59,000USD49,000USD39,000USD33,000USD
    Capital Stock43,000USD31,000USD15,000USD118,024,000USD0USD———
    Retained Earnings-336,729,000USD-174,392,000USD-89,423,000USD-45,868,000USD-325,567,000USD-254,431,000USD-179,495,000USD-102,726,000USD
    Cash51,087,000USD22,792,000USD132,325,000USD15,365,000USD131,650,000USD58,152,000USD65,071,000USD58,345,000USD
    Cash And Short Term Investments404,295,000USD275,241,000USD173,718,000USD75,490,000USD176,926,000USD148,835,000USD145,729,000USD142,570,000USD
    Total Current Assets409,438,000USD280,904,000USD177,451,000USD82,033,000USD180,693,000USD151,527,000USD149,843,000USD145,321,000USD
    Total Current Liabilities30,732,000USD18,452,000USD9,631,000USD8,225,000USD10,863,000USD11,430,000USD14,115,000USD10,419,000USD
    Current Deferred Revenue1,188,000USD479,000USD100,000USD100,000USD————
    Net Debt-49,701,000USD-21,301,000USD-131,740,000USD-14,577,000USD-131,650,000USD-58,152,000USD-65,071,000USD-58,345,000USD
    Short Term Debt367,000USD320,000USD417,000USD350,000USD————
    Short Long Term Debt Total1,386,000USD1,491,000USD585,000USD788,000USD————
    Long Term Investments110,135,000USD81,728,000USD0USD—————
    Short Term Investments353,208,000USD252,449,000USD41,393,000USD60,125,000USD45,276,000USD90,683,000USD80,658,000USD84,225,000USD
    Net Receivables102,000USD807,000USD478,000USD5,638,000USD1,476,000USD———
    Accounts Payable9,725,000USD4,579,000USD2,610,000USD1,167,000USD3,040,000USD3,760,000USD2,812,000USD3,492,000USD
    Property Plant Equipment Net1,633,000USD1,747,000USD800,000USD956,000USD7,461,000USD8,312,000USD9,891,000USD3,070,000USD
    Property Plant Equipment Gross1,937,000USD1,940,000USD897,000USD986,000USD33,000USD———
    Accumulated Other Comprehensive Income489,000USD106,000USD47,000USD-161,000USD-30,000USD-23,000USD8,000USD-8,000USD
    Common Stock Shares Outstanding37,794,088shares33,314,000shares5,153,423shares3,747,183shares3,434,300shares2,745,007shares2,313,429shares2,082,100shares
    Non Current Assets Total121,484,000USD93,104,000USD1,954,000USD1,077,000USD9,241,000USD10,092,000USD11,671,000USD11,992,000USD
    Non Current Liabilities Total6,789,000USD3,079,000USD904,000USD1,229,000USD6,399,000USD6,283,000USD6,206,000USD1,246,000USD
    Non Currrent Assets Other9,716,000USD9,629,000USD1,154,000USD121,000USD30,000USD1USD1,780,000USD-1USD
    Net Working Capital378,706,000USD262,452,000USD167,820,000USD73,808,000USD4,036,000USD———
    Unclassified Non Current Liabilities6,789,000USD3,079,000USD——6,399,000USD6,283,000USD6,206,000USD1,246,000USD
    Unclassified Equity829,555,000USD526,701,000USD258,216,000USD1,600,000USD498,210,000USD398,311,000USD320,641,000USD248,349,000USD
    Other Liab———791,000USD————
    Other Assets———121,000USD30,000USD——1USD
    Inventory———852,000USD264,000USD———
    Net Tangible Assets———-44,368,000USD-17,249,000USD———
    Unclassified Non Current Assets————1,720,000USD1,779,999USD—8,921,999USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USD
    Net Income-40,834,000USD-36,765,000USD-31,629,000USD-29,511,000USD-28,440,000USD-25,174,000USD-17,607,000USD-13,748,000USD
    Depreciation76,000USD99,000USD99,000USD133,000USD78,000USD116,000USD111,000USD107,000USD
    Stock Based Compensation10,602,000USD5,794,000USD5,706,000USD5,315,000USD3,918,000USD3,840,000USD3,101,000USD2,035,000USD
    Other Non Cash Items-916,000USD-2,538,000USD-1,120,000USD-1,904,000USD-2,578,000USD-2,648,000USD-422,000USD-518,000USD
    Change To Account Receivables-1,178,000USD-4,961,000USD961,000USD-193,000USD1,876,000USD-1,008,000USD-799,000USD-398,000USD
    Change In Working Capital2,216,000USD2,855,000USD3,052,000USD-1,663,000USD-422,000USD2,599,000USD289,000USD-2,817,000USD
    Total Cash From Operating Activities-28,856,000USD-30,555,000USD-23,892,000USD-27,630,000USD-27,444,000USD-21,267,000USD-14,528,000USD-14,941,000USD
    Capital Expenditures-10,000USD-5,000USD-46,000USD-24,000USD-31,000USD-25,000USD-17,000USD-32,000USD
    Free Cash Flow-28,866,000USD-30,560,000USD-23,938,000USD-27,654,000USD-27,475,000USD-21,292,000USD-14,545,000USD-14,973,000USD
    Investments-133,963,000USD-201,275,000USD26,445,000USD14,794,000USD-23,110,000USD-259,364,000USD1,169,000USD-5,507,000USD
    Total Cashflows From Investing Activities-133,973,000USD-201,275,000USD26,445,000USD14,794,000USD-23,110,000USD-259,363,999USD1,169,000USD-5,507,000USD
    Total Cash From Financing Activities739,410,000USD274,513,000USD568,000USD161,000USD39,676,000USD296,000USD-2,196,000USD217,847,000USD
    Sale Purchase Of Stock120,000USD————-49,704,000USD——
    Issuance Of Capital Stock736,355,000USD272,268,000USD0USD0USD39,200,000USD0USD0USD229,998,000USD
    Change In Cash576,581,000USD42,683,000USD3,121,000USD-12,676,000USD-10,878,000USD-280,498,000USD-15,555,000USD197,399,000USD
    Begin Period Cash Flow51,254,000USD13,468,000USD10,347,000USD22,792,000USD33,900,000USD314,169,000USD329,724,000USD132,325,000USD
    End Period Cash Flow627,835,000USD56,151,000USD13,468,000USD10,116,000USD23,022,000USD33,671,000USD314,169,000USD329,724,000USD
    Other Cashflows From Financing Activities739,410,000USD274,513,000USD—32,000USD476,000USD166,243,000USD-217,576,000USD-12,151,000USD
    Unclassified Financing Cash Flow—-272,268,000USD———-116,243,000USD215,380,000USD—
    Net Borrowings————0USD0USD——
    Other Cashflows From Investing Activities—————-195,999USD-17,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-162,337,000USD-84,969,000USD-43,555,000USD-28,476,000USD-71,136,000USD-74,936,000USD-76,769,000USD-57,515,000USD
    Depreciation428,000USD412,000USD355,000USD147,000USD2,020,000USD1,978,000USD1,843,000USD875,000USD
    Stock Based Compensation22,793,000USD12,894,000USD2,900,000USD1,518,000USD63,000USD9,941,000USD10,001,000USD10,703,000USD
    Other Non Cash Items-6,670,000USD-6,166,000USD-762,000USD-606,000USD11,111,000USD23,070,000USD22,534,000USD10,020,000USD
    Change To Account Receivables755,000USD0USD5,160,000USD-4,162,000USD-1,476,000USD———
    Change In Working Capital16,726,000USD-351,000USD4,862,000USD-1,653,000USD-1,526,000USD-1,186,000USD8,831,000USD3,984,000USD
    Total Cash From Operating Activities-129,060,000USD-78,180,000USD-36,861,000USD-29,070,000USD-59,531,000USD-64,022,999USD-57,103,000USD-41,886,000USD
    Capital Expenditures-213,000USD-105,000USD-110,000USD-139,000USD-1,264,000USD-400,000USD-3,060,000USD-7,672,000USD
    Free Cash Flow-129,273,000USD-78,285,000USD-36,971,000USD-29,209,000USD-60,795,000USD-64,423,000USD-60,163,000USD-49,558,000USD
    Investments-122,620,000USD-286,812,000USD15,825,000USD-59,819,000USD-33,000USD———
    Total Cashflows From Investing Activities-122,833,000USD-286,812,000USD20,253,000USD-59,819,000USD43,428,000USD-10,635,000USD1,532,000USD-91,703,000USD
    Total Cash From Financing Activities280,125,000USD255,623,000USD133,574,000USD96,676,000USD89,601,000USD67,739,000USD62,297,000USD142,147,000USD
    Sale Purchase Of Stock317,000USD——————-88,000USD
    Issuance Of Capital Stock272,268,000USD269,198,000USD72,000,000USD100,000,000USD15,000,000USD———
    Change In Cash28,232,000USD-109,369,000USD116,966,000USD7,787,000USD73,498,000USD-6,919,000USD6,726,000USD6,778,000USD
    Begin Period Cash Flow23,022,000USD132,391,000USD15,425,000USD7,638,000USD58,152,000USD65,071,000USD58,345,000USD51,567,000USD
    End Period Cash Flow51,254,000USD23,022,000USD132,391,000USD15,425,000USD131,650,000USD58,152,000USD65,071,000USD58,345,000USD
    Other Cashflows From Financing Activities280,125,000USD-13,575,000USD61,574,000USD96,676,000USD15,000,000USD-10,635,000USD1,532,000USD49,235,000USD
    Net Borrowings—0USD0USD0USD————
    Unclassified Investing Cash Flow——4,538,000USD—88,186,000USD-10,235,000USD4,592,000USD-84,043,000USD
    Change To Inventory———4,162,000USD————
    Change To Liabilities———3,171,000USD4,919,000USD———
    Other Cashflows From Investing Activities———175,000USD-43,461,000USD——12,000USD
    Unclassified Financing Cash Flow———-100,000,000USD59,601,000USD78,374,000USD60,765,000USD93,000,000USD
    Unclassified Operating Cash Flow—————-22,889,999USD-23,543,000USD-9,953,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31ProductLicense463,000USD0001690585-26-000022
    Q1 2026Quarterly · 2026-03-31ProductOther37,000USD0001690585-26-000022
    Q1 2026Quarterly · 2026-03-31ProductRoyalty0USD0001690585-26-000022
    FY 2025Yearly · 2025-12-31ProductLicense2,036,000USD0001690585-26-000006
    FY 2025Yearly · 2025-12-31ProductRoyalty0USD0001690585-26-000006
    Q1 2025Quarterly · 2025-03-31ProductLicense1,163,000USD0000950170-25-069226
    Q1 2025Quarterly · 2025-03-31ProductRoyalty0USD0000950170-25-069226
    FY 2024Yearly · 2024-12-31ProductLicense6,235,000USD0000950170-25-037131
    FY 2024Yearly · 2024-12-31ProductRoyalty0USD0000950170-25-037131
    Q1 2024Quarterly · 2024-03-31ProductLicense0USD0000950170-25-069226
    Q1 2024Quarterly · 2024-03-31ProductLicense Revenue900,000USD0000950170-25-069226
    FY 2023Yearly · 2023-12-31ProductLicense0USD0000950170-25-037131
    FY 2023Yearly · 2023-12-31ProductLicense Revenue2,800,000USD0000950170-25-037131
    FY 2023Yearly · 2023-12-31ProductOther26,000USD0000950170-25-037131

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.